Stay updated on NYX-2925 Efficacy & Safety in DPN Clinical Trial

Sign up to get notified when there's something new on the NYX-2925 Efficacy & Safety in DPN Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the NYX-2925 Efficacy & Safety in DPN Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Added a Locations section listing study sites across AZ, CA, CT, FL, GA, ID, IL, MO, NJ, NY, OH, TN, TX, and VA, and removed several state-specific location subsections and the HHS Vulnerability Disclosure.
    Difference
    1%
    Check dated 2025-12-23T09:45:16.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    43 days ago
    Change Detected
    Summary
    Revision tag updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-24T21:03:30.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The banner about a lapse in government funding and related operating status was removed from the page. It previously directed users to cc.nih.gov and opm.gov for status updates.
    Difference
    0.3%
    Check dated 2025-11-17T18:24:26.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    No significant changes detected between the two screenshots; the page content and layout appear unchanged.
    Difference
    0.4%
    Check dated 2025-11-03T13:11:42.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    Added a prominent government funding notice and a new v3.2.0 version tag; removed the old v3.1.0 version tag.
    Difference
    3%
    Check dated 2025-10-13T05:07:32.000Z thumbnail image
  9. Check
    100 days ago
    Change Detected
    Summary
    Adds v3.1.0 and removes several drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) while also removing the previous version v3.0.2; overall, the page’s scope appears to shift away from detailed drug-safety content.
    Difference
    0.4%
    Check dated 2025-09-29T02:57:02.000Z thumbnail image

Stay in the know with updates to NYX-2925 Efficacy & Safety in DPN Clinical Trial

Enter your email address, and we'll notify you when there's something new on the NYX-2925 Efficacy & Safety in DPN Clinical Trial page.